Mucopolysaccharidosis IIIA
Rare Disease·MeSH: Mucopolysaccharidosis III
Prevalence
5.0 / 100K
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
Frequently asked questions
How many drugs are in development for Mucopolysaccharidosis IIIA?
BioSniper tracks 1 drug in development for Mucopolysaccharidosis IIIA across 1 company.
How many clinical trials target Mucopolysaccharidosis IIIA?
There are 1 clinical trial targeting Mucopolysaccharidosis IIIA tracked by BioSniper.
What is the prevalence of Mucopolysaccharidosis IIIA?
The estimated prevalence of Mucopolysaccharidosis IIIA is approximately 5.0 per 100,000 population.
Deep-dive into Mucopolysaccharidosis IIIA
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis